Bortezomib blocks Bax degradation in malignant B cells during treatment with TRAIL. (Q42523097)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Bortezomib blocks Bax degradation in malignant B cells during treatment with TRAIL. |
scientific article |
Statements
Bortezomib blocks Bax degradation in malignant B cells during treatment with TRAIL (English)
Samir G Agrawal
John G Gribben
Hongtao Ye
Ming-Qing Du
Adrian C Newland
26 December 2007